Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study.

Search TravelDoctorOnline

Authors: Badiee P,Alborzi A,
Address: Prof. Alborzi Microbiology Research Center, Mycology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Journal: Iran J Microbiol.


Publication: 2011 Dec;3(4):183-8.

abstract

BACKGROUND AND OBJECTIVES:

The incidence of fungal infections in immunocompromised patients, especially by Candida species, has increased in recent years. This study was designed to identify Candida species and determine antifungal Susceptibility patterns of 595 yeast strains isolated from various clinical specimens.

MATERIAL AND METHODS:

Identification of the isolates were determined by the API 20 C AUX kit and antifungal susceptibilities of the species to fluconazole, amphotericin B, ketoconazole, itraconazole, voriconazole, and caspofungin were determined by the agar-based E-test method.

RESULTS:

Candida albicans (48%) was the most frequently isolated species, followed by Candida kruzei (16.1%), Candida glabrata (13.5%), Candida kefyr (7.4%), Candida parapsilosis (4.8%), Candida tropicalis (1.7%) and other species (8.5%). Resistance varies depending on the species and the respective antifungal agents. Comparing the MIC90 for all the strains, the lower MIC90 was observed for caspofungin (0.5 µg/ml). The MIC90 for all Candida species were 64 µg/ml for fluconazole, 0.75 µg/ml for amphotericin B, 4 µg/ml for ketoconazole, 4 µg/ml for itraconazole, and 2 µg/ml for voriconazole.

CONCLUSIONS:

Species definition and determination of antifungal susceptibility patterns are advised for the proper management and treatment of patients at risk for systemic candidiasis. Resistance to antifungal agents is an alarming sign for the emerging common nosocomial fungal infections.



Related Articles
[Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Mikrobiyol Bul. 2010
[Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK, Mutlu B, Dündar D, Willke A. Mikrobiyol Bul. 2010 Apr; 44(2):263-71.
In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
J Med Microbiol. 2011
In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
Amran F, Aziz MN, Ibrahim HM, Atiqah NH, Parameswari S, Hafiza MR, Ifwat M. J Med Microbiol. 2011 Sep; 60(Pt 9):1312-6. Epub 2011 Apr 1.
Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
J Med Microbiol. 2007
Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
Mokaddas EM, Al-Sweih NA, Khan ZU. J Med Microbiol. 2007 Feb; 56(Pt 2):255-9.
[Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Mikrobiyol Bul. 2011
[Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S, Fındık D, Arslan U. Mikrobiyol Bul. 2011 Jan; 45(1):137-49.
Review Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
J Hosp Infect. 2002
Review Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V, Barnes AJ. J Hosp Infect. 2002 Apr; 50(4):243-60.
Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis.
Iran J Microbiol. 2013
Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis.
Mahmoudabadi AZ, Najafyan M, Moghimipour E, Alwanian M, Seifi Z. Iran J Microbiol. 2013 Mar; 5(1):86-90.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.